El Granada, CA, United States of America

James Blanchard

This inventor holds 15 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent, primarily in Pharmaceutical Formulations. Top assignees: Aradigm Corporation, Grifols, S.a., Oregon State University. Active years: 2007-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Blanchard. Retrieved from https://idiyas.com/inventor/james-blanchard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 2)

% Patents Active = 13.3

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 2.4

ph-index = 8

Forward Citations = 251(Granted Patents)

Company Filing History:

Oregon State University

patents

where one patent can have more than one assignee

Years Active: 2007-2021

Loading Chart...

Areas of Expertise:

Liposomal Formulations

Ciprofloxacin

Inhalable Antibiotics

Nanocrystals

Dual Action

Sustained Release

Non-Tuberculous Mycobacteria

Erectile Dysfunction

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11116765 - Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria (2021-09-14),

2. 11026941 - Concentrated, inhalable ciprofloxacin formulation (2021-06-08),

3. 10420765 - Concentrated, inhalable ciprofloxacin formulation (2019-09-24),

4. 10376508 - Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria (2019-08-13),

5. 9844548 - Liposomal ciprofloxacin formulations with encapsulated ciprofloxacin nanocrystals (2017-12-19),

6. 9545401 - Concentrated, inhalable ciprofloxacin formulation (2017-01-17),

7. 9532986 - Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria (2017-01-03),

8. 9259424 - Concentrated, inhalable antibiotic formulation (2016-02-16),

9. 9078897 - Concentrated, inhalable antibiotic formulation (2015-07-14),

10. 9028864 - Concentrated, inhalable antibiotic formulation (2015-05-12),

11. 8414915 - Dual action, inhaled formulations providing both an immediate and sustained release profile (2013-04-09),

12. 8268347 - Dual action, inhaled formulations providing both an immediate and sustained release profile (2012-09-18),

13. 8119156 - Dual action, inhaled formulations providing both an immediate and sustained release profile (2012-02-21),

14. 8071127 - Dual action, inhaled formulations providing both an immediate and sustained release profile (2011-12-06),

15. 7258850 - Methods and compositions for treating erectile dysfunction (2007-08-21),

Title: The Innovative Contributions of James Blanchard

Introduction

James Blanchard is a notable inventor based in El Granada, California. He has made significant contributions to the field of medical formulations, particularly in the treatment of respiratory infections. With a total of 15 patents to his name, Blanchard's work has had a profound impact on the development of new therapeutic methods.

Latest Patents

Among his latest patents, Blanchard has developed liposomal ciprofloxacin formulations that are effective against non-tuberculous mycobacteria. These formulations include methods for treating NTM lung infections using liposomal ciprofloxacin. Additionally, he has created a concentrated inhalable formulation of ciprofloxacin, which is designed for aerosolization and inhalation to treat respiratory tract infections and other medical conditions. These innovations highlight his commitment to advancing medical treatments.

Career Highlights

Blanchard has worked with prominent organizations such as Aradigm Corporation and Oregon State University. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in antibiotic formulations.

Collaborations

Some of his notable coworkers include David C. Cipolla and Igor Gonda. Their collaborative efforts have contributed to the success of his innovative projects.

Conclusion

James Blanchard's work exemplifies the spirit of innovation in the medical field. His patents and collaborations have paved the way for new treatments that can significantly improve patient outcomes.

Profile summary based on public USPTO records.